Youcare Pharmaceutical Group Co., Ltd. (SHA:688658)
China · Delayed Price · Currency is CNY 13.80
-0.04 (-0.29%)
Sep 23, 2026, 3:00 PM CST
SHA:688658 Revenue
Youcare Pharmaceutical Group had revenue of 625.11M CNY in the quarter ending June 30, 2026, with 5.95% growth. This brings the company's revenue in the last twelve months to 2.46B, down -17.96% year-over-year. In the year 2025, Youcare Pharmaceutical Group had annual revenue of 2.45B, down -35.30%.
Revenue (ttm)
2.46B
Revenue Growth
-17.96%
P/S Ratio
2.49
Revenue / Employee
849.98K
Employees
2,894
Market Cap
6.13B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.45B | -1.33B | -35.30% |
| Dec 31, 2024 | 3.78B | -415.42M | -9.90% |
| Dec 31, 2023 | 4.20B | -345.64M | -7.61% |
| Dec 31, 2022 | 4.54B | -423.78M | -8.53% |
| Dec 31, 2021 | 4.97B | 626.78M | 14.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 15.93B |
| Novogene | 2.28B |
| Chengdu Kanghua Biological Products | 1.22B |
| Boji Medical Technology | 961.34M |
| R&G PharmaStudies | 939.31M |
| Wuhan Keqian Biology Co.,Ltd | 836.28M |
| Zhejiang Ausun Pharmaceutical | 778.50M |
| Jiangsu Aidea Pharmaceutical Group | 722.54M |